REIJU
Live / Applied — Non-final action mailed (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 06 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99638506
- Mark type
- Stylized text
- Filed
- 06 Feb 2026
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 27 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2026 — NON-FINAL ACTION E-MAILED
- 27 Mar 2026 — NON-FINAL ACTION WRITTEN
- 26 Mar 2026 — ASSIGNED TO EXAMINER
- 06 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 06 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Feb 2026 — NEW APPLICATION ENTERED